Compounds > technetium tc 99m sestamibi
Page last updated: 2024-08-16

technetium tc 99m sestamibi and Lymphoproliferative Disorders

technetium tc 99m sestamibi has been researched along with Lymphoproliferative Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Disel, U; Ergin, M; Guney, IB; Paydas, S; Yapar, Z; Yavuz, S1

Other Studies

1 other study(ies) available for technetium tc 99m sestamibi and Lymphoproliferative Disorders

ArticleYear
Post transplant lymphoproliferative disease: detection of tumor by Tc99m sestaMIBI and treatment with rituximab.
    Bone marrow transplantation, 2005, Volume: 35, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Hematopoietic Stem Cell Transplantation; Humans; Lymphoproliferative Disorders; Male; Rituximab; Technetium Tc 99m Sestamibi

2005